L3

Sudden cardiac death is the most feared complication of Hypertrophic Cardiomyopathy. This inherited heart muscle disease affects 1 in 500 people. But we are poor at identifying those who really need a potentially life-saving implantable cardioverter-defibrillator. Measuring the abnormalities believed to trigger fatal ventricular arrhythmias could guide treatment. Myocardial disarray is the hallmark feature of patients who die suddenly but is currently a post mortem finding. Through recent advances, the microstructure of the myocardium can now be examined by mapping the preferential diffusion of water molecules along fibres using Diffusion Tensor Cardiac Magnetic Resonance imaging. Fractional anisotropy calculated from the diffusion tensor, quantifies the directionality of diffusion.  Here, we show that fractional anisotropy demonstrates normal myocardial architecture and provides a novel imaging biomarker of the underlying substrate in hypertrophic cardiomyopathy which relates to ventricular arrhythmia.

The pRED Clinical Pharmacology Disease Modelling Group (CPDMG) aims to better understand the biological basis of inter-patient variability of clinical response to drugs.  Improved understanding of how our drugs drive clinical responses informs which combination dosing regimens (“right drugs”) specific patient populations (“right patients”) are most likely to benefit from. Drug evoked responses are driven by drug-molecular-target interactions that perturb target functions. These direct, "proximal effects" (typically activation and/or inhibition of protein function) propagate across the biological processes these targets participate in via “distal effects” to drive clinical responses. Clinical Systems Pharmacology approaches are used by CPDMG to predict the mechanisms by which drug combinations evoke observed clinical responses. Over the last 5 years, CPDMG has successfully applied these approaches to inform key decisions across clinical development programs. Implementation of these approaches requires: (i) integration of prior relevant biological/clinical knowledge with large clinical and “omics” datasets; (ii) application of supervised machine learning (specifically, Artificial Neural Networks (ANNs)) to transform this knowledge/data into actionable, clinically relevant, mechanistic insights.  In this presentation, key features of these approaches will be discussed by way of clinical examples.  This will provide a framework for outlining the current limitations of these approaches and how we plan to address them in the future.

Single cell RNA-Seq data is challenging to analyse due to problems like dropout and cell type identification. We present a novel clustering 
approach that applies mixture models to learn interpretable clusters from RNA-Seq data, and demonstrate how it can be applied to publicly 
available scRNA-Seq data from the mouse brain. Having inferred groupings of the cells, we can then attempt to learn networks from the data. These 
approaches are widely applicable to single cell RNA-Seq datasets where  there is a need to identify and characterise sub-populations of cells.

Globally, almost 38 million people are living with HIV.  HPTN 071 (PopART) is the largest HIV prevention trial to date, taking place in 21 communities in Zambia and South Africa with a combined population of more than 1 million people.  As part of the trial an individual-based mathematical model was developed to help in planning the trial, to help interpret the results of the trial, and to make projections both into the future and to areas where the trial did not take place. In this talk I will outline the individual-based mathematical model used in the trial, the inference framework, and will discuss examples of how the results from the model have been used to help inform policy decisions.  

This challenge relates to problems (of a mathematical nature) in generating optimal solutions for natural flood management.  Natural flood management involves large numbers of small scale interventions in a much larger context through exploiting natural features in place of, for example, large civil engineering construction works. There is an optimisation problem related to the catchment hydrology and present methods use several unsatisfactory simplifications and assumptions that we would like to improve on.

We consider the coordinate-iterated-integral as an algebraic product on the shuffle algebra, called the (right) half-shuffle product. Its anti-symmetrization defines the biproduct  area(.,.), interpretable as the signed-area between two real-valued coordinate paths. We consider specific sets of binary, rooted trees known as Hall sets. These set have a complex combinatorial structure, which can be almost entirely circumvented by introducing the equivalent notion of Lazard sets. Using analytic results from dynamical systems and algebraic results from the theory of Lie algebras, we show that shuffle-polynomials in areas-of-areas on Hall trees generate the shuffle algebra.

I will elaborate on some recent developments on the theory of special functions which are relevant to the calculation of Feynman integrals in perturbative quantum field theory, highlighting the connections with some recent ideas in pure mathematics.

The sequence of so-called Signature moments describes the laws of many stochastic processes in analogy with how the sequence of moments describes the laws of vector-valued random variables. However, even for vector-valued random variables, the sequence of cumulants is much better suited for many tasks than the sequence of moments. This motivates the study of so-called Signature cumulants. To do so, an elementary combinatorial approach is developed and used to show that in the same way that cumulants relate to the lattice of partitions, Signature cumulants relate to the lattice of so-called "ordered partitions". This is used to give a new characterisation of independence of multivariate stochastic processes.